![]() IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies. | |||
Founding Date | Founding Date 2018 | Founding Date 2014 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Poitiers, FR HQ Chasseneuil Du Poitou, FR | Locations New York, US HQ København, DK Usk, GB Rockville, US | Locations Gaithersburg, US HQ |
Employees | Employees 833% increase | Employees 19 | Employees 78 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 85.3 m | Valuation ($) 4.7 b |
Financial | |||
Net income | Net income N/A | Net income ($95.5m) (FY, 2024) | Net income ($228.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 720.5k | Total funding raised $ 165.9m | Total funding raised $ 200m |

IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
View company
Arcellx is a clinical-stage biotechnology company developing adaptive immune cell therapies.
View company